Healthcare

Medtronic, Inc. today announced the start of ENGAGE¹, the largest ever study of its kind, which will evaluate the performance of the Endurant stent graft, an implantable medical device designed to provide an advanced minimally-invasive alternative to open surgical repair of abdominal aortic aneurysms.

A ground breaking ice pack, which has benefits for both osteoarthritis patients and athletes, has been launched by North Yorkshire healthcare innovations company, Salitas.

Cordis Corporation, a leading developer and manufacturer of breakthrough treatments for cardiovascular disease, is celebrating its 50th anniversary this month.

According to Millennium Research Group’s US Markets for Large-Joint Reconstructive Implants 2009 report, hip resurfacing will be the fastest-growing segment of the large-joint reconstructive implant market through 2013, rising at a compound annual growth rate of over 25%.

NovaLign Orthopedics Inc. can now market its first product, a bone fixation system, after it received clearance from the Food and Drug Administration.

Abbott today announced the initiation of the next phase of the ABSORB clinical trial to evaluate the safety and performance of the company’s fully bioabsorbable drug eluting coronary stent.

KARL STORZ Endoscopy-America, Inc., a world leader in minimally invasive endoscopic technologies and fully integrated operating room solutions, announces that it has entered into a definitive agreement with InTouch Health®, the world leader in Remote Presence healthcare solutions.

Cardinal Health today launched nine new products targeted to improve the safety and efficiency within operating rooms, including high-performance surgical scrubs, a high-tech mobile fluid management system, advances in automated medical supply dispensing and new surgical instruments.

Medtronic said Friday that at least 13 people might have died in connection with a heart device that it recalled in 2007 but was still in widespread use.

Injections of bone cement to support weakened bones in patients with metastatic bone disease provide immediate and substantial pain relief for patients, a researcher reported here at the Society of Interventional Radiology (SIR) 34th Annual Scientific Meeting.

The Board of Directors of the North American Skull Base Society has made the decision to postpone the annual NASBS meeting until October 2009

Information Portal Consumer Injury Lawyers continues to update its Zimmer Durom Hip Replacement Part information portal with new articles providing more detail and insight relating to Zimmer Hip Implant Lawsuits.

As the number of hip and knee replacements skyrocket into the coming years, patients and orthopaedic surgeons need to evaluate and assess a potentially fatal complication — blood clots. According to findings released today at the 2009 Annual Meeting of the American Academy of Orthopaedic Surgeons, deep vein thrombosis a type of prophylaxis a patient receives pre and post-joint replacement, causes controversy.

Giving patients with acute vertebral fractures balloon kyphoplasty treatment improves quality of life and reduces disability and back pain compared with conventional non-surgical management, and is a safe and effective technique, finds The Lancet.

Bone Biologics, Inc. announced that it has successfully completed the initial primate trials validating the efficacy of the proprietary bone growth regeneration UCB-1 (NELL-1) protein in spinal fusion surgery.

Biomedical engineers at The University of Texas Health Science Center at Houston are leading a multi-institution initiative to produce a bio-compatible compound designed to mend serious leg fractures.